HIKMA (LON:HIK) Director/PDMR Shareholding

Transparency directive : regulatory news

17/05/2018 13:10
Hikma Pharmaceuticals Plc  -  HIK   

Director/PDMR Shareholding


Released 13:10 17-May-2018

 


Hikma Pharmaceuticals PLC - EIP Vesting


LONDON, 17 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 11 May 2016 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 16 May 2018.  


Notification and public disclosure of transactions by persons discharging managerial responsibilities


Hussein Arkhagha













































































1



Details of the person discharging managerial responsibilities / person closely associated



a)



Name



Hussein Arkhagha



2



Reason for the notification



a)



Position/status



PDMR



b)



Initial notification /Amendment



Initial notification



3



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



a)



Name



Hikma Pharmaceuticals PLC



b)



LEI



549300BNS685UXH4JI75



4



Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted



a)



Description of the financial instrument, type of instrument and identification code



Description: Ordinary shares of 10 pence each (Shares)


ID Code: GB00B0LCW083



b)



Nature of the transaction


 



Shares acquired from vesting of the conditional awards on

16 May 2018 under the 2014 EIP Element B.



c)



Price(s) and volume(s)



Price(s): £nil


Volume(s): 7,749



d)



Aggregated information



N/A



e)



Date of the transaction



16 May 2018



f)



Place of the transaction



London Stock Exchange (XLON)



Bryan Hotston













































































1



Details of the person discharging managerial responsibilities / person closely associated



a)



Name



Bryan Hotston



2



Reason for the notification



a)



Position/status



PDMR



b)



Initial notification /Amendment



Initial notification



3



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



a)



Name



Hikma Pharmaceuticals PLC



b)



LEI



549300BNS685UXH4JI75



4



Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted



a)



Description of the financial instrument, type of instrument and identification code



Description: Ordinary shares of 10 pence each (Shares)


ID Code: GB00B0LCW083



b)



Nature of the transaction


 



Shares acquired from vesting of the conditional awards on

16 May 2018 under the 2014 EIP Element B.



c)



Price(s) and volume(s)



Price(s): £13.18


Volume(s): 1,860



d)



Aggregated information



Volume: 1,860


Price: £13.18


Total: £24,514.80



e)



Date of the transaction



16 May 2018



f)



Place of the transaction



London Stock Exchange (XLON)



 


Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760


 



HIKMA's latest news


18/05/2018 13:01
18/05/2018 07:00
17/05/2018 13:45
17/05/2018 13:10
03/05/2018 09:00
01/05/2018 13:38
26/04/2018 13:40
25/04/2018 10:41
24/04/2018 09:00
20/04/2018 09:00